Legend Biotech LEGN
NASDAQ LEGN
$18.63 -0.38 (-2.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Legend Biotech (LEGN) EV to EBIT (2023 - 2024)

Updated

Legend Biotech's EV to EBIT was 59.52 in Q1 2025, up 360.7% from 12.92 a year earlier and up 289.1% from the prior quarter.

Analysis

Legend Biotech (LEGN) EV to EBIT (2023 - 2024) Analysis & Trends

On a trailing twelve-month basis, Legend Biotech's EV to EBIT was 18.48 through Mar 31, 2025, up 151.6% year-over-year; for FY2022, it was 15.81, up 7.3% from FY2021.

  • In earlier years, EV to EBIT was 14.74 in FY2021 (+52.6%) and 9.66 in FY2020.
  • The Q1 2025 figure marks the highest quarterly EV to EBIT since Q4 2022.
  • Compared with a year earlier, EV to EBIT was higher in two of the last six quarters, with growth averaging 18.1%.
  • Per Business Quant data, LEGN's EV to EBIT in the three quarters before Q1 2025 was 15.30 (Q4 2024), 13.22 (Q3 2024) and 8.24 (Q2 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Legend Biotech 3.42 Bn 924.58 Mn 251.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 36.52
Mar 31, 2024 31.57
Dec 31, 2023 38.86
Sep 30, 2023 42.93
Jun 30, 2023 55.13
API Access

Legend Biotech EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=LEGN&period=max&api_key=YOUR_API_KEY